Co-Morbidities Associated with Generalized Myasthenia Gravis: Improving Patient Quality of Life

Program Overview
Significant developments are currently taking place in the treatment and management paradigm of patients with comorbid conditions associated with gMG creating knowledge gaps for translating these advances into clinical decision-making. This activity will focus on consensus recommendations on how to evaluate and manage comorbid conditions including tolerability of drugs as a therapeutic modality.

Learning Objectives
Upon completion of this activity, participants should be better able to:

Identify potential common comorbid conditions associated with generalized myasthenia gravis (gMG)
Describe management challenges of associated comorbid conditions when treating patients with gMG
Evaluate the safety and efficacy of incorporating multiple pharmacologic treatments when managing patients with gMG